Wendler David, Wesley Bob, Pavlick Mark, Rid Annette
Department of Bioethics, NIH Clinical Center, Bethesda, Maryland, USA.
Biostatistics & Clinical Epidemiology Service, NIH Clinical Center, Bethesda.
J Med Ethics. 2016 Apr;42(4):235-41. doi: 10.1136/medethics-2015-103001. Epub 2016 Jan 29.
Surrogates frequently are unable to predict which treatment their charges would want and also can experience significant distress as a result of making treatment decisions. A new method, the patient preference predictor (PPP), has been proposed as a possible way to supplement the process of shared decision-making to address these two concerns. The PPP predicts which treatment the patient would want based on which treatment similar patients want in similar circumstances. The present article describes the results of the first evaluation to assess whether patients support the use of a PPP.
Self-administered survey of patients at a tertiary care centre.
Overall, 1169 respondents completed the survey (response rate=59.8%). In the event that the respondent became unable to make decisions due to a car accident, 78.9% would want the PPP to be incorporated into the process of making treatment decisions for them. In contrast, 15.2% of respondents would not want the PPP to be used for them. Respondents who endorsed the PPP cited the possibility that its use could increase the chances that they receive the treatments they prefer and/or reduce the burdens on their surrogate decision-maker.
The majority of respondents endorsed the possibility of incorporating a PPP into the process of shared decision-making based on its potential to increase surrogates' predictive accuracy and/or reduce surrogate distress. These data provide strong patient support for further research to assess whether, in practice, the use of a PPP can increase the chances that incapacitated patients receive the treatments they prefer and reduce the burden of making decisions on their surrogates.
代理人常常无法预测其委托人希望接受哪种治疗,而且由于做出治疗决策,他们自身也可能会经历巨大的痛苦。一种新方法——患者偏好预测器(PPP)已被提出,作为补充共同决策过程的一种可能方式,以解决这两个问题。PPP基于类似患者在类似情况下希望接受哪种治疗来预测患者希望接受哪种治疗。本文描述了首次评估的结果,以评估患者是否支持使用PPP。
对一家三级医疗中心的患者进行自填式调查。
总体而言,1169名受访者完成了调查(回复率=59.8%)。如果受访者因车祸而无法做出决策,78.9%的人希望将PPP纳入为他们做出治疗决策的过程。相比之下,15.2%的受访者不希望为他们使用PPP。认可PPP的受访者提到,使用它有可能增加他们接受自己偏好治疗的机会和/或减轻其代理决策者的负担。
大多数受访者认可将PPP纳入共同决策过程的可能性,因为其有可能提高代理人的预测准确性和/或减轻代理人的痛苦。这些数据为进一步研究提供了有力的患者支持,以评估在实际应用中,使用PPP是否能够增加无行为能力患者接受其偏好治疗的机会,并减轻其代理人的决策负担。